Search results
J.M. Smucker price target cut to $135, retains 'buy' rating By Investing.com
Investing.com· 2 hours agoOn Friday, TD (TSX:TD) Cowen adjusted its outlook on J.M. Smucker (NYSE:NYSE:SJM), reducing the ...
Semtech shares target cut to $45, maintains 'buy' rating By Investing.com
Investing.com· 2 hours agoOn Friday, Stifel adjusted its price target for Semtech Corp . Despite this change, the firm...
Snowflake stock target cut, maintains buy rating on transitional phase By Investing.com
Investing.com· 3 hours agoOn Friday, Jefferies made a significant adjustment to Snowflake Inc .'s (NYSE:SNOW) financial...
Friday's biggest analyst calls: Microsoft price target increase, Lyft gets an upgrade
CNBC· 11 hours agoPlease refresh every 20-30 minutes to view the latest posts.) Microsoft and Lyft were among the...
Now Prices Are Going … Down?
The Cut· 1 day agoLast week, Walgreens announced price cuts on 1,300 items — including vitamins, tampons, skin-care products, and groceries — because the company...
Truist cuts Samsara shares target, cites current market valuations By Investing.com
Investing.com· 7 hours agoOn Friday, Truist Securities adjusted its outlook on Samsara Inc (NYSE:IOT) shares, reducing the ...
Citi maintains buy on Lululemon stock, price target steady By Investing.com
Investing.com· 2 hours agoOn Friday, Citi reaffirmed its positive stance on Lululemon Athletica Inc. (NASDAQ: NASDAQ:LULU),...
Scotiabank cuts Biomea Fusion shares target, notes FDA clinical hold concerns By Investing.com
Investing.com· 8 hours agoOn Friday, Scotiabank (TSX:BNS) revised its price target for Biomea Fusion Inc. (NASDAQ: BMEA)...
Vail Resorts shares target cut by Stifel on revised EBITDA By Investing.com
Investing.com· 10 hours agoOn Friday, Stifel adjusted its price target for Vail Resorts (NYSE:MTN) shares, a prominent player...
Maxim cuts Avenue Therapeutics shares target, highlights upcoming trial data By Investing.com
Investing.com· 8 hours agoOn Friday, Maxim (NASDAQ:MXIM) Group adjusted its stance on Avenue Therapeutics (NASDAQ:ATXI)...